These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19567131)
21. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377 [TBL] [Abstract][Full Text] [Related]
22. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study. Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340 [TBL] [Abstract][Full Text] [Related]
23. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Tait MJ; Petrik V; Loosemore A; Bell BA; Papadopoulos MC Br J Neurosurg; 2007 Oct; 21(5):496-500. PubMed ID: 17852105 [TBL] [Abstract][Full Text] [Related]
24. Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC. Stark AM; Stepper W; Mehdorn HM Eur J Cancer Care (Engl); 2010 Jan; 19(1):39-44. PubMed ID: 19912295 [TBL] [Abstract][Full Text] [Related]
25. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883 [TBL] [Abstract][Full Text] [Related]
26. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883 [TBL] [Abstract][Full Text] [Related]
27. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. McGirt MJ; Mukherjee D; Chaichana KL; Than KD; Weingart JD; Quinones-Hinojosa A Neurosurgery; 2009 Sep; 65(3):463-9; discussion 469-70. PubMed ID: 19687690 [TBL] [Abstract][Full Text] [Related]
28. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880 [TBL] [Abstract][Full Text] [Related]
29. [Survival prediction for terminal gynecologic cancer patients]. Sun XG; Ma SQ; Wu M; Li CY; Jin LN; Shen K Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):160-3. PubMed ID: 16638320 [TBL] [Abstract][Full Text] [Related]
30. Impact of removed tumor volume and location on patient outcome in glioblastoma. Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405 [TBL] [Abstract][Full Text] [Related]
31. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. Wang L; Wei Q; Wang LE; Aldape KD; Cao Y; Okcu MF; Hess KR; El-Zein R; Gilbert MR; Woo SY; Prabhu SS; Fuller GN; Bondy ML J Clin Oncol; 2006 Apr; 24(10):1627-32. PubMed ID: 16575014 [TBL] [Abstract][Full Text] [Related]
32. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer. Rades D; Fischer D; Veninga T; Stalpers LJ; Schild SE Gynecol Oncol; 2009 Sep; 114(3):506-8. PubMed ID: 19540574 [TBL] [Abstract][Full Text] [Related]
34. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846 [TBL] [Abstract][Full Text] [Related]
35. The natural history of EGFR and EGFRvIII in glioblastoma patients. Heimberger AB; Suki D; Yang D; Shi W; Aldape K J Transl Med; 2005 Oct; 3():38. PubMed ID: 16236164 [TBL] [Abstract][Full Text] [Related]
36. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years. Kumar P; Singh S; Kumar P; Krishnani N; Datta NR J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388 [TBL] [Abstract][Full Text] [Related]
37. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis. Prayson NF; Angelov L; Prayson RA Ann Diagn Pathol; 2009 Oct; 13(5):291-6. PubMed ID: 19751904 [TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031 [TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants. Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512 [TBL] [Abstract][Full Text] [Related]
40. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Helseth R; Helseth E; Johannesen TB; Langberg CW; Lote K; Rønning P; Scheie D; Vik A; Meling TR Acta Neurol Scand; 2010 Sep; 122(3):159-67. PubMed ID: 20298491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]